Elisha Shalim

Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

Saifullah Baig, Shaukat Ali, Sadaf Khan, 2021, EClinicalMedicine.

Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial

Sajid Ali, Ayesha Ali, F. Anjum, 2022, Trials.

Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma

Shaukat Ali, R. Ali, Ayesha Ali, 2021, Immunotherapy.

Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from Karachi, Pakistan

Ishfaq Ahmed, Maheen Q. Khan, Fizza Farooqui, 2023, Vaccines.

Outcome of Acute Kidney Injury in Critical COVID-19 patients in Karachi, Pakistan: A Single center, Retrospective study

Anam Haider, Elisha Shalim, S. Afzal, 2023 .